PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations

Inhibition of the PD-1/PD-L1 pathway may induce anticancer immune responses in non-small cell lung cancer (NSCLC). Two PD-L1 immunohistochemistry (IHC) assays have been approved as companion diagnostic tests for therapeutic anti-PD-1 antibodies. However, many aspects of PD-L1 prevalence and associat...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncoimmunology
Huvudupphovsmän: Scheel, Andreas H., Ansén, Sascha, Schultheis, Anne M., Scheffler, Matthias, Fischer, Rieke N., Michels, Sebastian, Hellmich, Martin, George, Julie, Zander, Thomas, Brockmann, Michael, Stoelben, Erich, Groen, Harry, Timens, Wim, Perner, Sven, von Bergwelt-Baildon, Michael, Büttner, Reinhard, Wolf, Jürgen
Materialtyp: Artigo
Språk:Inglês
Publicerad: Taylor & Francis 2016
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4910698/
https://ncbi.nlm.nih.gov/pubmed/27467949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1131379
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk